How do we solve the puzzle of unintended consequences of inflammation? Systematically.
Miles
Mary P
MP
D000818:Animals; D035843:Biomedical Research / Q000379:methods; D001831:Body Temperature; D002432:Cecum / Q000382:microbiology / Q000601:surgery; D004195:Disease Models, Animal; D018450:Disease Progression; D006801:Humans; D008070:Lipopolysaccharides; D009538:Nicotine / Q000008:administration & dosage; D018722:Nicotinic Agonists / Q000008:administration & dosage; D012107:Research Design; D018805:Sepsis / Q000150:complications* / Q000382:microbiology / Q000503:physiopathology; D013375:Substance Withdrawal Syndrome / Q000150:complications / Q000503:physiopathology; D018746:Systemic Inflammatory Response Syndrome / Q000139:chemically induced / Q000150:complications* / Q000503:physiopathology; D014029:Tobacco Use Disorder / Q000150:complications / Q000503:physiopathology
D008070:Lipopolysaccharides; D018722:Nicotinic Agonists; D009538:Nicotine